Skip to content

Hypertension and prevention for dementia or frail in the aging society; the Karuizawa study.

Hypertension and prevention for dementia or frail in the aging society; the Karuizawa study. - Hypertension and prevention for dementia or frail in the aging society; the Karuizawa study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000041739
Enrollment
300
Registered
2020-09-10
Start date
2020-09-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General population of the elderly

Interventions

None listed

Sponsors

Shinshu-University
Lead Sponsor
1) Karuizawa city 2) TOYO Corporation Co., Ltd. 3) Shinshu university, faculty of engineering 4) Immuno-Biological Laboratories Co,Ltd.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) those who have a certificate of residence of the Karuizawa city. 2) those who have the national health insurance or the medical insurance for the elderly aged 75 or over. 3) those who already have visited for the specific health examination or the health checkup for older senior citizens, or who are planning to visit for those health examinations.

Exclusion criteria

Exclusion criteria: 1) those who have already been diagnosed as dementia. 2) those who cannot express their intention to consent to participate in this study by themselves. 3) those who are not expected to be able to measure their home blood pressures or urine tests by themselves. 4) those who are judged to be unsuitable to participate in this study by the contact personnel.

Design outcomes

Primary

MeasureTime frame
Development of dementia, by measuring cognitive function using MMSE and MoCA-J, and consecutively by examination of specialist only for those of suspected dementia.

Secondary

MeasureTime frame
1) Development of frail 2) All-cause death 3) Development of depression 4) Development of hypertension 5) Development of cardiovascular disease 6) hospitalization

Countries

Japan

Contacts

Public ContactChie Fujimaki

Shinshu-University Reseach Center for Social Systems

fujimaki_chie@gm.shinshu-u.ac.jp0267-31-5360

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026